MedPath

Crossover comparative study of latanoprost/timolol fixed combination with combined therapy comprised of latanoprost and timolol

Not Applicable
Conditions
glaucoma, ocular hypertension
Registration Number
JPRN-UMIN000005426
Lead Sponsor
Department of Ophthalmology, Gifu University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Contraindication for latanoprost or timolol MD worse than or equal to -25dB (HFA 30-2) BCVA less than 0.5 Refractive error greater than or equal to +9.0D, or less than -9.0D Goldmann applanation tomometry or disc evaluation difficult or impossible History of intraocular surgery or laser Other ocular diseases which may affect the results

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IOP after 8-week treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath